MTDR P/E Ratio Analysis
Updated 444h ago·SEC filings & market data
Key Takeaway
The P/E ratio of 8.5x means investors pay $8.50 for every $1 of the company's yearly earnings.
Sector Performance
6th percentileMTDR
8.5x
Sector Median
23.1x
Sector Avg
33.8x
Prior Period
12.8x(Jul 2026)
Deep Analysis
The P/E ratio of 8.5x means investors pay $8.50 for every $1 of the company's yearly earnings.
That is far below the sector median of 23.2x, placing the stock at the 5th percentile among its sector peers, so most comparable companies trade at much higher multiples. The year-over-year change is N/A, but the quarter-over-quarter change is -33.3%, as the ratio fell from 12.8x to 8.5x. A low P/E relative to peers can point to a cheaper valuation, though the sharp quarterly decline suggests earnings rose, the stock price fell, or both. The combination of a very low level and a falling trend carries both opportunity—if the market is underpricing earnings—and risk, if earnings are expected to deteriorate. This metric supports the overall NEUTRAL verdict because it signals a value case but does not confirm a strong catalyst.
Frequently Asked Questions
What does the P/E Ratio tell investors about MTDR?
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
How is the P/E Ratio calculated?
P/E Ratio is calculated as: Price / EPS.
Who are MTDR's closest peers by P/E Ratio?
The closest peers by P/E Ratio include: CMCSA (7.8x), EG (7.8x), CHRD (7.7x), OXY (7.4x), THC (7.3x).
Learn More About P/E Ratio
The Formula
Price / EPS
Why It Matters
Measures how much investors pay per dollar of earnings. A high P/E signals growth expectations; a low P/E may indicate undervaluation or slow growth.
Master MTDR's Valuation
Get the complete institutional research report covering all fundamental and technical metrics.
View full MTDR research report →MTDR
8.5x
Sector Median
23.1x
Sector Avg
33.8x
How MTDR's P/E Ratio compares to sector peers.
Also Analyze
Not financial advice. Research tool only. Data may be delayed.